Announcements Trials

Browse Landscape

Phase

Status

Terminated 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 17 Neoplasm Metastasis 9 Carcinoma, Non-Small-Cell Lung 6 Neoplasms 3 Melanoma 3 Brain Neoplasms 3 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Rhabdoid Tumor 2 Pancreatic Neoplasms 2 Osteosarcoma 2 Neuroblastoma 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Mantle-Cell 2 Lymphoma 2 Head and Neck Neoplasms 2 Glioma 2 Glioblastoma 2 Diffuse Intrinsic Pontine Glioma 2 Colorectal Neoplasms 2 Advanced Cancer 2 Urologic Neoplasms 1 Unilateral Breast Neoplasms 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Recurrence 1 Prostatic Neoplasms 1 Multiple Myeloma 1

Interventions

Dexamethasone 362 Bortezomib 231 Lenalidomide 200 Cyclophosphamide 174 Melphalan 154 Calcium Dobesilate 107 Peripheral Blood Stem Cell Transplantation 92 fludarabine phosphate 84 Thalidomide 81 Filgrastim 71 carfilzomib 68 pomalidomide 66 Granulocyte Colony-Stimulating Factor 60 Mycophenolic Acid 59 Busulfan 57 daratumumab 54 Whole-Body Irradiation 54 Tacrolimus 51 ixazomib 50 Prednisone 50 Cyclosporine 49 fludarabine 46 Antilymphocyte Serum 35 Etoposide 30 dexamethasone acetate 29 Methotrexate 29 plerixafor 27 Radiotherapy 26 Doxorubicin 26 dexamethasone 21-phosphate 25

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Multiple Myeloma × abemaciclib × Clear all

NCT03732703 2025-02-14

MyDRUG

Multiple Myeloma Research Consortium

Phase 1/2 Completed

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡